Cargando…

Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use

IMPORTANCE: Although HIV preexposure prophylaxis (PrEP) implementation among persons who inject drugs has been inadequate, national HIV monitoring programs do not include data on PrEP, and specific trends in PrEP use are not well understood. OBJECTIVE: To estimate HIV PrEP uptake among commercially...

Descripción completa

Detalles Bibliográficos
Autores principales:	Streed, Carl G., Morgan, Jake R., Gai, Mam Jarra, Larochelle, Marc R., Paasche-Orlow, Michael K., Taylor, Jessica L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277489/ https://www.ncbi.nlm.nih.gov/pubmed/35819784 http://dx.doi.org/10.1001/jamanetworkopen.2022.21346

Ejemplares similares

Effect of 6-Month HIV Preexposure Prophylaxis Dispensing With Interim Self-testing on Preexposure Prophylaxis Continuation at 12 Months: A Randomized Noninferiority Trial
por: Ortblad, Katrina F., et al.
Publicado: (2023)

Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Examination of HIV Preexposure Prophylaxis Need, Availability, and Potential Pharmacy Integration in the Southeastern US
por: Harrington, Kristin R. V., et al.
Publicado: (2023)

Association of Incarceration With Mortality by Race From a National Longitudinal Cohort Study
por: Bovell-Ammon, Benjamin J., et al.
Publicado: (2021)

The European preexposure prophylaxis revolution
por: Cairns, Gus, et al.
Publicado: (2016)

The use of preexposure treatments for HIV prophylaxis
por: Majid, Adrian, et al.
Publicado: (2012)

Eligibility for HIV Preexposure Prophylaxis, Intention to Use Preexposure Prophylaxis, and Informal Use of Preexposure Prophylaxis Among Men Who Have Sex With Men in Amsterdam, the Netherlands
por: Hulstein, Sebastiaan H., et al.
Publicado: (2021)

Geographic Variation in Qualified Health Plan Coverage and Prior Authorization Requirements for HIV Preexposure Prophylaxis
por: McManus, Kathleen A., et al.
Publicado: (2023)

A Preliminary Study of the Attitudes and Barriers of Family Physicians to Prescribing HIV Preexposure Prophylaxis
por: Ojile, Nicholas, et al.
Publicado: (2017)

Statistical issues in trials of preexposure prophylaxis
por: Dunn, David T., et al.
Publicado: (2016)

Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use–Associated Infective Endocarditis
por: Adams, Joëlla W., et al.
Publicado: (2022)

Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System
por: Hojilla, J. Carlo, et al.
Publicado: (2021)

Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women
por: Anderson, Peter L., et al.
Publicado: (2016)

Oral preexposure prophylaxis continuation, measurement and reporting
por: Stankevitz, Kayla, et al.
Publicado: (2020)

Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition
por: Fonner, Virginia A., et al.
Publicado: (2023)

Incidence and Characteristics of Nonfatal Opioid Overdose Among Youths Aged 11 to 24 Years by Sex
por: Bagley, Sarah M., et al.
Publicado: (2020)

Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis
por: Ahluwalia, Amrit Kaur, et al.
Publicado: (2022)

Increased HIV Transmissions With Reduced Insurance Coverage for HIV Preexposure Prophylaxis: Potential Consequences of Braidwood Management v. Becerra
por: Paltiel, A David, et al.
Publicado: (2023)

P41 - Preexposure prophylaxis of infants’ food allergy
por: Denisova, Svetlana, et al.
Publicado: (2014)

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion
por: Donnell, Deborah, et al.
Publicado: (2017)

Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
por: Fonner, Virginia A., et al.
Publicado: (2016)

Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China: A Nonrandomized Controlled Trial
por: Wang, Hongyi, et al.
Publicado: (2022)

Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria
por: Nishimoto, Lirica, et al.
Publicado: (2023)

Preexposure prophylaxis strategies for African–American women affected by mass incarceration
por: Adams, Joëlla W., et al.
Publicado: (2021)

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study
por: Grinsztejn, Beatriz, et al.
Publicado: (2023)

Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review and Meta-analysis
por: Ong, Jason J., et al.
Publicado: (2019)

Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men
por: McManus, Hamish, et al.
Publicado: (2020)

Adherence to Preexposure Prophylaxis: Current, Emerging, and Anticipated Bases of Evidence
por: Amico, K. Rivet, et al.
Publicado: (2014)

Weighing the Risk of Drug Resistance With the Benefits of HIV Preexposure Prophylaxis
por: Grant, Robert M., et al.
Publicado: (2015)

Preexposure Prophylaxis for the Prevention of HIV Infection — 2014 Available Online
Publicado: (2014)

Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States
por: Aaron, Erika, et al.
Publicado: (2018)

HIV Preexposure Prophylaxis in the U.S. Military Services — 2014–2016
por: Blaylock, Jason M., et al.
Publicado: (2018)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
por: Knox, David C., et al.
Publicado: (2022)

Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV
por: Nguyen, Vinh-Kim, et al.
Publicado: (2018)

Comparison of a Prototype for Indications-Based Prescribing With 2 Commercial Prescribing Systems
por: Garabedian, Pamela M., et al.
Publicado: (2019)

Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020
por: Tanner, Mary R., et al.
Publicado: (2020)

A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis
por: Fuchs, Jonathan D., et al.
Publicado: (2018)

HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016
por: Huang, Ya-lin A., et al.
Publicado: (2018)

Women Trust Their OBGYNs to Provide Preexposure Prophylaxis: An Opportunity for HIV Prevention
por: Danvers, Antoinette A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j4slep41b795bqjt9geb2v4l2p